Immunomic Therapeutics

1 follower

Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the Universal Intracellular Targeted Expression (UNITE) nucleic acid immunotherapy platform.

Industries

Employees

11-50

Links


Org chart

SVP, Regulatory Affairs
VP, Quality Assurance
Associate Director, Vaccine Discovery of Research and Development
Senior Scientist
Director, RNA Therapeutic Development

Board & advisors

Director
Director
Director
Chief Executive Officer
Scientific Advisory Board
Scientific Advisory Board
Scientific Advisory Board
Scientific Advisor
Scientific Advisor
Director
Director